Research Projects & Grants

For Profit Organization

  • Evaluation of patient outcomes from the kidney allograft outcomes allosure registry (KOAR), Role: Investigator, CareDx, Inc., (10/2025 - 10/2026) Status: Approved
  • A phase 3 prospective, randomized, multi-center, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-matched, living donor kidney transplants, Role: Investigator, Medeor Therapeutics, Inc., (05/2023 - 04/2024) Status: Completed
  • A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 3 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) (TRANSCEND), Role: Investigator, Biogen, (04/2026 - 04/2027) Status: Approved
  • Biogen MA Inc/ "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants with Late Isolated Microvascular Inflammation (MVI) - (TRANSPIRE}" 299AR201, Role: Investigator, Biogen, (03/2026 - 03/2027) Status: Approved

Internal

  • Highly Suppressive Regulatory T Cell as a Biomarker for Immunologically Relevant Delayed/Slow Graft Function after Kidney Transplantation, Role: Investigator, LLU Dept. of Surgery, (10/2020) Status: Approved
  • Incidence of Glomerular Disease Post-Kidney Transplant, Role: PI, LLU Dept. of Medicine, (10/2024) Status: Approved
  • Assessment of IVIG in highly sensitized patients with panel reactive antigen (PRA) of over 94%., Role: Investigator, LLU Transplantation Institute, (04/2025) Status: Approved
  • Transplantation of HCV positive donor kidneys in HCV negative or previously successfully treated recipients, Role: Investigator, LLU Transplantation Institute, (11/2025 - 11/2026) Status: Approved
  • Comparing Antithymocyte Globulin and Basiliximab Induction Therapy in Pancreas Transplant Patients: A Single-institution Retrospective Study, Role: Investigator, LLU Transplantation Institute, (10/2025) Status: Approved

Non-Profit Organization

  • Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation, Role: Investigator, American Society of Transplant Surgeons, (08/2025 - 08/2026) Status: Approved